China Cancer Diagnostics Market Report & Forecast 2021-2027

China Cancer Diagnostics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Cancer Diagnostics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Cancer Diagnostics Overall Market Size
2.1 China Cancer Diagnostics Market Size: 2021 VS 2027
2.2 China Cancer Diagnostics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Diagnostics Players in China Market
3.2 Top China Cancer Diagnostics Companies Ranked by Revenue
3.3 China Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Cancer Diagnostics Companies in China Market, by Revenue in 2020
3.5 Companies Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Diagnostics Players in China Market
3.6.1 List of Tier 1 Cancer Diagnostics Companies in China
3.6.2 List of Tier 2 and Tier 3 Cancer Diagnostics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Cancer Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Platform-based
4.1.3 Instrument-based
4.2 By Type - China Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - China Cancer Diagnostics Revenue, 2016-2021
4.2.2 By Type - China Cancer Diagnostics Revenue, 2022-2027
4.2.3 By Type - China Cancer Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Cancer Diagnostics Market Size, 2021 & 2027
5.1.2 Breast Cancer
5.1.3 Lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Others
5.2 By Application - China Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - China Cancer Diagnostics Revenue, 2016-2021
5.2.2 By Application - China Cancer Diagnostics Revenue, 2022-2027
5.2.3 By Application - China Cancer Diagnostics Revenue Market Share, 2016-2027
6 Cancer Diagnostics Companies Profiles
6.1 Becton, Dickinson and Company
6.1.1 Becton, Dickinson and Company Company Details
6.1.2 Becton, Dickinson and Company Business Overview
6.1.3 Becton, Dickinson and Company Cancer Diagnostics Introduction
6.1.4 Becton, Dickinson and Company Cancer Diagnostics Revenue in China Market (2016-2021)
6.1.5 Becton, Dickinson and Company Recent Developments
6.2 GE Healthcare
6.2.1 GE Healthcare Company Details
6.2.2 GE Healthcare Business Overview
6.2.3 GE Healthcare Cancer Diagnostics Introduction
6.2.4 GE Healthcare Cancer Diagnostics Revenue in China Market (2016-2021)
6.2.5 GE Healthcare Recent Developments
6.3 Abbott
6.3.1 Abbott Company Details
6.3.2 Abbott Business Overview
6.3.3 Abbott Cancer Diagnostics Introduction
6.3.4 Abbott Cancer Diagnostics Revenue in China Market (2016-2021)
6.3.5 Abbott Recent Developments
6.4 Roche
6.4.1 Roche Company Details
6.4.2 Roche Business Overview
6.4.3 Roche Cancer Diagnostics Introduction
6.4.4 Roche Cancer Diagnostics Revenue in China Market (2016-2021)
6.4.5 Roche Recent Developments
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Company Details
6.5.2 Thermo Fisher Scientific Business Overview
6.5.3 Thermo Fisher Scientific Cancer Diagnostics Introduction
6.5.4 Thermo Fisher Scientific Cancer Diagnostics Revenue in China Market (2016-2021)
6.5.5 Thermo Fisher Scientific Recent Developments
6.6 Agilent Technologies
6.6.1 Agilent Technologies Company Details
6.6.2 Agilent Technologies Business Overview
6.6.3 Agilent Technologies Cancer Diagnostics Introduction
6.6.4 Agilent Technologies Cancer Diagnostics Revenue in China Market (2016-2021)
6.6.5 Agilent Technologies Recent Developments
6.7 Illumina
6.7.1 Illumina Company Details
6.7.2 Illumina Business Overview
6.7.3 Illumina Cancer Diagnostics Introduction
6.7.4 Illumina Cancer Diagnostics Revenue in China Market (2016-2021)
6.7.5 Illumina Recent Developments
6.8 Siemens Healthcare
6.8.1 Siemens Healthcare Company Details
6.8.2 Siemens Healthcare Business Overview
6.8.3 Siemens Healthcare Cancer Diagnostics Introduction
6.8.4 Siemens Healthcare Cancer Diagnostics Revenue in China Market (2016-2021)
6.8.5 Siemens Healthcare Recent Developments
6.9 C.R. Bard
6.9.1 C.R. Bard Company Details
6.9.2 C.R. Bard Business Overview
6.9.3 C.R. Bard Cancer Diagnostics Introduction
6.9.4 C.R. Bard Cancer Diagnostics Revenue in China Market (2016-2021)
6.9.5 C.R. Bard Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Cancer Diagnostics Market Opportunities & Trends in China Market
Table 2. Cancer Diagnostics Market Drivers in China Market
Table 3. Cancer Diagnostics Market Restraints in China Market
Table 4. Key Players of Cancer Diagnostics in China Market
Table 5. Top Cancer Diagnostics Players in China Market, Ranking by Revenue (2019)
Table 6. China Cancer Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Cancer Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Companies Cancer Diagnostics Product Type
Table 9. List of Tier 1 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 17. Becton, Dickinson and Company Company Details
Table 18. Becton, Dickinson and Company Business Overview
Table 19. Becton, Dickinson and Company Cancer Diagnostics Product
Table 20. Becton, Dickinson and Company Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Becton, Dickinson and Company Recent Developments
Table 22. GE Healthcare Company Details
Table 23. GE Healthcare Business Overview
Table 24. GE Healthcare Cancer Diagnostics Product
Table 25. GE Healthcare Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. GE Healthcare Recent Developments
Table 27. Abbott Company Details
Table 28. Abbott Business Overview
Table 29. Abbott Cancer Diagnostics Product
Table 30. Abbott Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Abbott Recent Developments
Table 32. Roche Company Details
Table 33. Roche Business Overview
Table 34. Roche Cancer Diagnostics Product
Table 35. Roche Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Roche Recent Developments
Table 37. Thermo Fisher Scientific Company Details
Table 38. Thermo Fisher Scientific Business Overview
Table 39. Thermo Fisher Scientific Cancer Diagnostics Product
Table 40. Thermo Fisher Scientific Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Thermo Fisher Scientific Recent Developments
Table 42. Agilent Technologies Company Details
Table 43. Agilent Technologies Business Overview
Table 44. Agilent Technologies Cancer Diagnostics Product
Table 45. Agilent Technologies Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Agilent Technologies Recent Developments
Table 47. Illumina Company Details
Table 48. Illumina Business Overview
Table 49. Illumina Cancer Diagnostics Product
Table 50. Illumina Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Illumina Recent Developments
Table 52. Siemens Healthcare Company Details
Table 53. Siemens Healthcare Business Overview
Table 54. Siemens Healthcare Cancer Diagnostics Product
Table 55. Siemens Healthcare Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Siemens Healthcare Recent Developments
Table 57. C.R. Bard Company Details
Table 58. C.R. Bard Business Overview
Table 59. C.R. Bard Cancer Diagnostics Product
Table 60. C.R. Bard Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 61. C.R. Bard Recent Developments
List of Figures
Figure 1. Cancer Diagnostics Segment by Type
Figure 2. Cancer Diagnostics Segment by Application
Figure 3. China Cancer Diagnostics Market Overview: 2020
Figure 4. China Cancer Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Cancer Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Cancer Diagnostics Revenue in 2020
Figure 7. By Type - China Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 8. By Application - China Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 9. Becton, Dickinson and Company Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. GE Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Abbott Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Roche Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Thermo Fisher Scientific Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Agilent Technologies Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Illumina Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Siemens Healthcare Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. C.R. Bard Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Prostate Cancer Diagnostics Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116

According to our LPI (LP Information) latest study, the global Prostate Cancer Diagnostics market size was valued at US$ 13140 million in 2023. With growing demand in downstream market, the Prostate Cancer Diagnostics is forecast to a readjusted size of US$ 22650 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global Prostate Cancer Diagnostics market. Prostate Cancer Diagnostics are expected to show stable growth in th......

Global Checkpoint Inhibitors for Treating Cancer Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 83

According to our LPI (LP Information) latest study, the global Checkpoint Inhibitors for Treating Cancer market size was valued at US$ 12220 million in 2023. With growing demand in downstream market, the Checkpoint Inhibitors for Treating Cancer is forecast to a readjusted size of US$ 63530 million by 2030 with a CAGR of 26.6% during review period. The research report highlights the growth potential of the global Checkpoint Inhibitors for Treating Cancer market. Checkpoint Inhibitors for......

Global PSA Test Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111

According to our LPI (LP Information) latest study, the global PSA Test market size was valued at US$ 499.9 million in 2023. With growing demand in downstream market, the PSA Test is forecast to a readjusted size of US$ 861.8 million by 2030 with a CAGR of 8.1% during review period. The research report highlights the growth potential of the global PSA Test market. PSA Test are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......

Global HPV Testing Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87

According to our LPI (LP Information) latest study, the global HPV Testing market size was valued at US$ 784.6 million in 2023. With growing demand in downstream market, the HPV Testing is forecast to a readjusted size of US$ 1398.7 million by 2030 with a CAGR of 8.6% during review period. The research report highlights the growth potential of the global HPV Testing market. HPV Testing are expected to show stable growth in the future market. However, product differentiation, reducing cos......

Global Prostate Cancer Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 102

According to our (Global Info Research) latest study, the global Prostate Cancer Diagnostics market size was valued at USD 13820 million in 2023 and is forecast to a readjusted size of USD 22870 million by 2030 with a CAGR of 7.5% during review period. The prostate is a walnut-sized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be ......

Global Pap Tests and HPV Tests Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 130

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Pap Tests and HPV Tests Professional Survey Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 106

The Pap test (or Pap smear) looks for precancers, cell changes on the cervix that might become cervical cancer if they are not treated appropriately. The HPV test looks for the virus (human papillomavirus) that can cause these cell changes. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can......

Global Checkpoint Inhibitors For Treating Cancer Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Checkpoint Inhibitors For Treating Cancer market: According to our latest research, the global Checkpoint Inhibitors For Treating Cancer market looks promising in the next 5 years. As of 2022, the global Checkpoint Inhibitors For Treating Cancer market was estimated at USD 18595.4 million, and it's anticipated to reach USD 42557.61 million in 2028, with a CAGR of 14.8% during the forecast years. Checkpoint inhibitor is a type of drug used in immunoth......

Global Solid Tumor Testing Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 100

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs